Health Equity Starts Here.
WHX Starts Now.
WHX Starts Now.
Dedicated to R&D and Clinicals Trials providing evidence generation and innovation
Stage 1: Evidence, Data & Innovation
Dedicated to R&D and Clinical Trials providing evidence generation and innovation, this stage highlights the science behind femtech. From inclusive trial design and regulatory pathways to pharma–startup partnerships and digital biomarkers, discover how research is closing the gender data gap and accelerating women’s health breakthroughs.
Main Visitors
- Pharma → pipeline scouting, trial innovation
- Clinical Trials Professionals → recruitment, endpoints, AI/digital biomarkers
- Clinicians → evidence-based updates
- Insurance Providers → review data/evidence and results to inform policy and reimbursement
Key Topics
Focus: R&D, clinical trials, regulatory science, digital biomarkers, evidence generation.
- Inclusive Clinical Trial Design: Representation of women, intersectional health data.
- AI & Digital Biomarkers: Accelerating trials, predictive endpoints.
- Regulatory Pathways: Navigating FDA, EMA, and global approvals.
- Pharma–Startup Collaborations: Co-development of novel therapies and devices.
- Evidence-Based Clinical Updates: Latest research shaping treatment and tech adoption.
- Data-Driven Outcomes: Real-world evidence, post-market surveillance, and outcome analytics.
- Recruitment & Retention Strategies: Innovative approaches for diverse trial populations.
